中国临床药理学与治疗学2025，Vol.30Issue(8)：1076-1083,8.DOI:10.12092/j.issn.1009-2501.2025.08.008
髓系来源抑制性细胞对非小细胞肺癌患者接受PD-1抑制剂联合化疗疗效与预后的影响
Myeloid-derived suppressor cells in predicting the efficacy and prog-nosis of PD-1 inhibitor combined with chemotherapy in non-small cell lung cancer patients
摘要
Abstract
AIM:To explore the relationship be-tween the level of myeloid-derived suppressor cell(MDSC)infiltration in tumor tissues and the clinical efficacy and prognosis of combined PD-1 inhibitor and chemotherapy in the treatment of advanced non-small cell lung cancer(NSCLC).METHODS:A retrospective analysis was conducted on 92 NSCLC patients who received PD-1 inhibitor combined with chemotherapy at the First Affiliated Hospital of Anhui Medical University from June 2019 to June 2024.Tumor tissue samples were examined using immunohistochemistry to detect the level of MDSC infiltration,dividing the patients into high-in-filtration group(MDSC≥2)and low-infiltration group(MDSC＜2).The objective response rate(iORR),disease control rate(iDCR),progression-free survival(PFS),and overall survival(OS)were compared between the two groups.Kaplan-Meier survival analysis and Log-rank test were used to plot PFS and OS survival curves,and Cox regression analysis was applied to identify factors influencing prognosis.RESULTS:Among the 92 patients,53 were in the low MDSC infiltration group,and 39 were in the high MDSC infiltration group.The low MDSC infiltration group showed significantly better treatment responses compared to the high MDSC infiltration group.The objective response rate(iORR)was 77.3％in the low MDSC infiltration group,higher than the 56.4％in the high MDSC in-filtration group(P=0.033).The disease control rate(iDCR)was 94.3％,also significantly higher than the 66.7％in the high MDSC infiltration group(P=0.001).Moreover,the median progression-free sur-vival(PFS)and overall survival(OS)in the low MD-SC infiltration group were 16.9 months and 27.6 months,respectively,which were significantly lon-ger than those in the high MDSC infiltration group(PFS 12.6 months,OS 22.3 months).Kaplan-Meier analysis revealed that both PFS and OS in the low MDSC infiltration group were significantly longer than those in the high MDSC infiltration group.Cox univariate analysis showed that smoking,PD-L1 ex-pression levels,tumor stage,and MDSC infiltration level were closely associated with PFS and OS.Mul-tivariate Cox regression analysis further indicated that high MDSC infiltration was an independent risk factor for both PFS(HR=2.678,P=0.013)and OS(HR=2.254,P=0.022).CONCLUSION:The level of MDSC infiltration in tumor tissues is closely related to the efficacy and prognosis of PD-1 inhibitor com-bined with chemotherapy in NSCLC patients.High MDSC infiltration suggests reduced treatment sen-sitivity and poor prognosis.MDSC infiltration level may serve as a predictive biomarker for the effica-cy and prognosis of PD-1 inhibitor combined with chemotherapy in advanced NSCLC.关键词
髓系来源抑制性细胞/非小细胞肺癌/PD-1抑制剂/化疗/疗效Key words
myeloid-derived suppressor cell/non-small cell lung cancer/PD-1 inhibitors/chemothera-py/efficacy分类
医药卫生引用本文复制引用
耿彪,孙珍贵,赵春阳,陈兴无..髓系来源抑制性细胞对非小细胞肺癌患者接受PD-1抑制剂联合化疗疗效与预后的影响[J].中国临床药理学与治疗学,2025,30(8):1076-1083,8.基金项目
安徽省重大自然科学项目基金(2023AH040266) （2023AH040266）
国家自然科学基金(82204458) （82204458）
芜湖市华佗计划卫生骨干人才项目 （）
